ATTENTION ALL CUSTOMERS:
Due to a recent change of our website, the process for submitting refill requests online has now changed.
Please click on “Sign Up Today!” to create a new account, and be sure to download our NEW Mobile app!
Thank you for your patience during this transition

Manténgase sano!

Resultados de su búsqueda "Cancer: Lymphoma".

Resultados de noticias de salud - 27

New Combo Drug Therapy Halves Death Risk From Advanced Hodgkin Lymphoma

Jenna Cottrell is a young sports reporter working for a TV station in the Rochester, N.Y., area.

She's also a survivor of advanced Hodgkin lymphoma, who first got diagnosed at the age of 25 back in 2017.

After 12 rounds of the then standard-of-care treatment chemotherapy, "I've been in remission since 2017," Cottrell said in an interview at the University of Rochester Medical Cente...

Outpatient CAR-T Cancer Therapy Can Be Safe, Effective

Patients with  a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study examining its use in a community setting has found.

CAR-T is shorthand for chimeric antigen receptor therapy. In this treatment, doctors remove the patient's own white blood cells, tweak them in a lab and then infuse them back into the patient to attack and kill ca...

Black, White Cancer Patients Now Benefit Equally From Cord Blood Therapy

Blood cancer patients of all races who receive cord blood transplants are now living longer.

The finding, reported by a team led by oncologist Dr. Karen Ballen, of UVA (University of Virginia) Health, shows that a previously identified survival gap for transplant recipients has been eliminated.

"Outcomes for cor...

Blood Cancers: What You Need to Know

Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.

First, blood cancers are far more common than you might think: One person in the United States is diagnosed with a 

  • Robin Foster HealthDay Reporter
  • |
  • September 28, 2024
  • |
  • Página completa
    • New Hope for People With Aggressive Form of Lymphoma

    An experimental cancer treatment regimen is achieving full remissions in some patients with aggressive B-cell lymphoma, researchers report. 

    The five-drug combination does not include chemotherapy. Rather, it simultaneously zeroes in on several molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors rely on to survive. B-cell lymphoma is a cancer of cells in the body's i...

    Could Tattoos Be Linked to Blood Cancer Risk?

    Research suggests that tattoo ink spurs inflammatory changes that might contribute to the development of lymphoma.

    The findings are early, however, and more study must be done to confirm any links between tattooing and the blood cancer, Swedish researchers stressed.

    "People will likely want to continue to express their identity through tattoos, and therefore it is very important tha...

    Strategy Could Expand Stem Cell Donor Pool for People Battling Blood Cancers

    An older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant, a new study finds.

    The drug, cyclophosphamide, could help patients receive a stem cell transplant even if the donor isn't a relative and only partially matches their blood type, researchers report.

    Blood cancer patients had a high ...

    New Drug Could Be Big Advance Against Rare Blood Cancer

    Polycythemia vera is a rare form of blood cancer with few good treatment options, but that may soon change based on the results of a new clinical trial.

    An injected experimental drug called rusfertide appears effective in reducing the excess production of red blood cells that's a hallmark of the disease.

    "Rusfertide appears to represent a significant step forward in treating polycyt...

    Major Study Confirms CT Scans' Link to Blood Cancer Risk in Kids

    CT scans are significantly linked to an increased risk of blood cancers in young people, a major multinational study has found.

    Analysis of data from nearly 1 million people under 22 who underwent at least one CT scan found a strong and clear link between exposure to the scans' radiation and blood cancers, according to findings published Nov. 9 in the journal

  • Dennis Thompson HealthDay Reporter
  • |
  • November 10, 2023
  • |
  • Página completa
    • Weight-Loss Surgery Could Lower Odds for Blood Cancers

    Weight-loss surgery can deliver a host of health benefits, but new research reveals an unexpected one: Getting the surgery was associated with a 40% lower risk of blood cancers.

    Being overweight or obese is a risk factor for several types of cancer, and women with obesity have a higher risk of cancer than men do.

    In the study, researchers used data from the Swedish Obese Subjects (...

    Fracking Tied to Lymphomas, Asthma in New Study

    Research into a possible link between childhood health problems and natural gas wells in western Pennsylvania is wrapping up with some answers.

    Children who lived near these wells were more likely to develop rare lymphoma, the research found.

    In addition, residents of all ages near the wells had increased risk of severe asthma reactions, the Associated Press reported.

    Can Some Cancer Patients Safely Skip Radiation Therapy? New Studies Say Yes

    Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.

    One trial found that rectal cancer patients whose tumors shrink in response to chemotherapy can safely skip the radiation therapy that's normally provided prior to surgery, researchers reported at the American Societ...

    Opdivo Could Boost Outcomes for People Battling Hodgkin Lymphoma

    The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clinical trial results show.

    Nivolumab outperformed the drug brentuximab vedotin (Adcetris), extending progression-free survival by 94% at one year compared to 86%, said lead researcher ...

    What to Do When Tough-to-Treat Lymphoma Strikes During Pregnancy

    Not a lot is known about how physicians should handle cases in which a pregnant woman is diagnosed with relapsed/refractory lymphoma.

    A new study may provide some perspective.

    Though uncommon, this issue is still experienced by about one in 4,000 women, according to background notes with the study published June 1 in

  • Cara Murez HealthDay Reporter
  • |
  • June 2, 2023
  • |
  • Página completa
    • Breakthrough CAR-T Cancer Treatments Are Boosting Patients' Quality of Life

    A therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds.

    The treatment, called chimeric antigen receptor (CAR) T-cell therapy, is used to fight certain types of blood cancer -- including leukemia and lymphoma -- that have not responded to standard treatments.

    It involves removing a patient's own immune system T-c...

    Jane Fonda Says Her Lymphoma Is in Remission

    Actress and two-time Academy Award winner Jane Fonda announced Thursday that her non-Hodgkin lymphoma is in remission.

    Fonda, 84, said in a blog post that she can quit chemotherapy treatments, calling it the "BEST BIRTHDAY PRESENT EVER!!!" Fonda, also a climate activist, will turn 85 on Wednesday.<...

    Race, Income Can Determine Blood Cancer Outcomes, Studies Show

    If someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.

    The ongoing impact of patient race and income to medical outcomes was in the spotlight Saturday in New Orleans at the annual meeting of the American Society of Hematology (ASH).

    In one study, a team led by

  • Ernie Mundell HealthDay Reporter
  • |
  • December 12, 2022
  • |
  • Página completa
    • She Thought Cancer Had Won -- Until This Experimental Therapy

    The breast cancer of author and poet Stephanie Gangi has receded and advanced in wearying waves for two decades now.

    First diagnosed and treated in 1999, Gangi's cancer spread to the bone of her sternum in 2014. In 2021, a tumor the size of an orange appeared on her adrenal gland.

    "I could not possibly tell you the number of treatments I've been through,"said Gangi, 66, of New York ...

    FDA Warns of Rare Cases of Certain Cancers Linked to Breast Implants

    The U.S. Food and Drug Administration on Thursday warned doctors and their patients about rare cases of squamous cell carcinoma and various lymphomas developing in the scar tissue that forms around breast implants.

    Jane Fonda Has Non-Hodgkin Lymphoma

    Actress Jane Fonda has announced she has non-Hodgkin lymphoma.

    Fonda, 84, said she has started chemotherapy to fight the highly treatable cancer, calling herself very lucky because 80% of patients survive.

    Also known for her social activism, Fonda noted she has health insurance and access to the best doc...

    For Blood Cancer Patients, COVID Boosters Can Bring Some Immunity

    In a promising development, new research has discovered that most adults with blood cancers develop at least some immunity to COVID-19 after getting booster shots.

    "Our findings build on the wealth of literature showing that patients with

  • By Ellie Quinlan Houghtaling HealthDay Reporter
  • |
  • July 11, 2022
  • |
  • Página completa
    • Ten Years After Gene Therapy for Leukemia, Doctors Say Patients Cured

    More than 10 years after Doug Olsen underwent an experimental gene therapy that turned his T-cells into cancer killers, his leukemia has vanished, University of Pennsylvania doctors report.

    "I'm doing great right now. I'm still very active. I wa...

    Many Cancer Patients Face Mounting Bills Despite Having Insurance

    Many insured cancer patients still experience serious money problems linked to their illness, new research affirms.

    For example, nearly 3 out of 4 insured patients with colon cancer have major financial hardship in the year after their diagnosis, which affects their social functioning and quality of life, according to

  • Steven Reinberg HealthDay Reporter
  • |
  • January 4, 2022
  • |
  • Página completa
    • Many Blood Cancer Patients Get Little Protection From COVID Vaccine

    Anti-vaxxers felt their suspicions confirmed when former U.S. Secretary of State Colin Powell died from COVID-19 complications in mid-October despite being fully vaccinated.

    But Powell, 84, was being treated for blood cancer at the time of his death, and a new study reports that the COVID vaccines are producing little to no protection for some cancer patients.

    Nearly 3 out of 5 bloo...

    Cancer Care Costs U.S. $156 Billion Per Year; Drugs a Major Factor

    Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.

    Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State College of Medicine study.

    "The public often hears that the U.S. spends an inordinate amount of money on health car...

    Jeff Bridges Says Cancer Is in Remission, But COVID Fight Was Tougher

    Jeff Bridges has had a rough year.

    Almost a year ago, the actor was diagnosed with lymphoma. Then in January, he was exposed to the COVID-19 virus while receiving chemotherapy.

    "Covid kicked my (expletive) pretty good," Bridges wrote in a blog post on his website, USA Today reported.

    Bridges, 71, said he spent five weeks in the hospital with COVID-19 because his immun...

    Blood Cancer Patients Could Benefit From COVID Booster Shot: Study

    Patients with B-cell blood cancers who did not make antibodies to COVID-19 after two shots of vaccine may find that a third shot does the trick, new research finds.

    More than half the patients who had failed to respond to the first two shots had a positive response to the third, or booster, shot, according to the Leukemia & Lymphoma Society study.

    "The additional COVID-19 vaccine do...